Stay updated on Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial

Sign up to get notified when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page

  1. Check
    11 days ago
    No Change Detected
  2. Check
    18 days ago
    No Change Detected
  3. Check
    25 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added and Revision: v3.4.3 has been removed.
    Difference
    0.0%
    Check dated 2026-03-21T20:53:10.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T13:00:19.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Fallopian tube cancer is now listed as a condition on the page, and the page revision updated to v3.4.2 (replacing v3.4.1).
    Difference
    0.1%
    Check dated 2026-02-13T17:41:27.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Added 'Primary peritoneal carcinoma' to the conditions/terms and introduced a resources entry for the Genetic and Rare Diseases Information Center. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-06T11:27:56.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.0 to v3.4.1. This appears to be a behind-the-scenes update with no visible changes to the study details or page content.
    Difference
    0.0%
    Check dated 2026-02-05T11:34:17.000Z thumbnail image
  9. Check
    84 days ago
    Change Detected
    Summary
    UI changes include a Show glossary toggle and updates to metadata labels (Last Update Submitted that Met QC Criteria; Revision: v3.4.0) with capitalization adjustments and No FEAR Act Data text; older capitalization variants appear to have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-29T06:21:53.000Z thumbnail image

Stay in the know with updates to Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.